Showing results (1071-1080 of 1,410) with videos related to
Sort By:
Pageof 141
BMJ Open Respiratory Research|December 7, 2021
Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countriesDaniele Pernigotti, Carol Stonham, Sara Panigone, et al.BMJ Open Respiratory Research|December 11, 2021
Extracorporeal CO2 removal in acute exacerbation of COPD unresponsive to non-invasive ventilationMathilde Azzi, Jerome Aboab, Sophie Alviset, et al.BMJ Open Respiratory Research|January 18, 2022
Effect of a postoperative home-based exercise and self-management programme on physical function in people with lung cancer (CAPACITY): protocol for a randomised controlled trialCatherine L Granger, Lara Edbrooke, Phillip Antippa, et al.BMJ Open Respiratory Research|December 10, 2021
Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA studyBradley E Chipps, Frank C Albers, Laurence Reilly, et al.BMJ Open Respiratory Research|March 23, 2021
Hyperlipidaemia and mortality among patients hospitalised with pneumonia: retrospective cohort and propensity score matched studyMohammed Yousufuddin, Umesh M Sharma, Sumit Bhagra, et al.BMJ Open Respiratory Research|December 25, 2021
Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective studySubash Heraganahally, Timothy P Howarth, Elisha White, et al.BMJ Open Respiratory Research|October 8, 2021
Novel method to select meaningful outcomes for evaluation in clinical trialsCharlie McLeod, Richard Norman, Jamie Wood, et al.BMJ Open Respiratory Research|June 11, 2019
Smoking and lung function among adults with newly onset asthmaJouni J K Jaakkola, Samu Hernberg, Taina K Lajunen, et al.BMJ Open Respiratory Research|June 11, 2019
Geographically linked risk factors for enrolment into a fast breathing child pneumonia trial in Lilongwe, Malawi: an Innovative Treatments in Pneumonia (ITIP) secondary analysisEvangelyn Nkwopara, Robert Schmicker, Tisungane Mvalo, et al.BMJ Open Respiratory Research|June 11, 2019
Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)Toby M Maher, Michael Kreuter, David J Lederer, et al.Pageof 141